Resources

Simtra is increasing its capabilities for standard- and high-potency sterile injectable manufacturing, offering customizable production solutions and commercial-scale OEB 5 fill/finish operations.

Simtra is expanding its prefilled syringe and vial manufacturing capacity to support highly reliable, scalable operations from development through commercial production.

During this webinar, learn more about Simtra’s recent investments across our manufacturing network and the capabilities supporting the next generation of injectable therapies.

As demonstrated in this case study, Simtra applies deep expertise in lyophilization optimization to overcome the two major challenges inherent in lyophilizing ADCs: phase separation during freezing and destabilization during drying.

This presentation highlights how Simtra BioPharma Solutions and MilliporeSigma collaborate to help improve scalability, reduce development risk, and ensure readiness for commercial manufacturing.

Yuliana Mendez presents an update of the ongoing capability expansions for Building H located at our Bloomington, Indiana campus.

Learn how shelf cooling rates influence supercooling, ice crystal formation, and primary drying time, and how optimized cooling strategies can enhance mass transfer efficiency and streamline lyophilization cycles.

Discover how controlling ice nucleation temperature can improve freeze-drying efficiency, reduce drying time, and create more consistent ice crystal structures compared to conventional freezing methods.

Discover how lyophilization is essential to the manufacture of ADCs, complex molecules that deliver precisely targeted therapies for a growing number of cancer types.